Alpha Cognition (ACOG) Competitors $9.97 +0.01 (+0.10%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock ACOG vs. IOVA, URGN, TLRY, TNGX, STOK, PRME, DNTH, PHAT, UPB, and XNCRShould you be buying Alpha Cognition stock or one of its competitors? The main competitors of Alpha Cognition include Iovance Biotherapeutics (IOVA), Urogen Pharma (URGN), Tilray Brands (TLRY), Tango Therapeutics (TNGX), Stoke Therapeutics (STOK), Prime Medicine (PRME), Dianthus Therapeutics (DNTH), Phathom Pharmaceuticals (PHAT), Upstream Bio (UPB), and Xencor (XNCR). These companies are all part of the "pharmaceutical products" industry. Alpha Cognition vs. Its Competitors Iovance Biotherapeutics Urogen Pharma Tilray Brands Tango Therapeutics Stoke Therapeutics Prime Medicine Dianthus Therapeutics Phathom Pharmaceuticals Upstream Bio Xencor Alpha Cognition (NASDAQ:ACOG) and Iovance Biotherapeutics (NASDAQ:IOVA) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, media sentiment, analyst recommendations and risk. Which has preferable valuation and earnings, ACOG or IOVA? Alpha Cognition has higher earnings, but lower revenue than Iovance Biotherapeutics. Alpha Cognition is trading at a lower price-to-earnings ratio than Iovance Biotherapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlpha CognitionN/AN/A-$14.64M-$1.20-8.31Iovance Biotherapeutics$212.68M4.91-$372.18M-$1.24-2.52 Which has more volatility & risk, ACOG or IOVA? Alpha Cognition has a beta of 2.73, meaning that its share price is 173% more volatile than the S&P 500. Comparatively, Iovance Biotherapeutics has a beta of 0.85, meaning that its share price is 15% less volatile than the S&P 500. Do analysts prefer ACOG or IOVA? Alpha Cognition presently has a consensus price target of $20.00, indicating a potential upside of 100.60%. Iovance Biotherapeutics has a consensus price target of $12.22, indicating a potential upside of 290.49%. Given Iovance Biotherapeutics' higher possible upside, analysts plainly believe Iovance Biotherapeutics is more favorable than Alpha Cognition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alpha Cognition 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Iovance Biotherapeutics 1 Sell rating(s) 6 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.33 Is ACOG or IOVA more profitable? Alpha Cognition has a net margin of 0.00% compared to Iovance Biotherapeutics' net margin of -176.49%. Iovance Biotherapeutics' return on equity of -49.71% beat Alpha Cognition's return on equity.Company Net Margins Return on Equity Return on Assets Alpha CognitionN/A -65.83% -48.21% Iovance Biotherapeutics -176.49%-49.71%-39.18% Do insiders & institutionals believe in ACOG or IOVA? 77.0% of Iovance Biotherapeutics shares are held by institutional investors. 14.0% of Alpha Cognition shares are held by company insiders. Comparatively, 10.3% of Iovance Biotherapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the media refer more to ACOG or IOVA? In the previous week, Iovance Biotherapeutics had 18 more articles in the media than Alpha Cognition. MarketBeat recorded 19 mentions for Iovance Biotherapeutics and 1 mentions for Alpha Cognition. Alpha Cognition's average media sentiment score of 1.87 beat Iovance Biotherapeutics' score of 0.14 indicating that Alpha Cognition is being referred to more favorably in the media. Company Overall Sentiment Alpha Cognition Very Positive Iovance Biotherapeutics Neutral SummaryIovance Biotherapeutics beats Alpha Cognition on 8 of the 15 factors compared between the two stocks. Get Alpha Cognition News Delivered to You Automatically Sign up to receive the latest news and ratings for ACOG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ACOG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACOG vs. The Competition Export to ExcelMetricAlpha CognitionMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$159.72M$3.04B$5.74B$9.51BDividend YieldN/A2.40%4.60%3.99%P/E Ratio-8.3121.2028.0820.03Price / SalesN/A338.37460.87103.88Price / CashN/A43.2336.5559.01Price / Book3.858.338.645.90Net Income-$14.64M-$55.19M$3.24B$258.66M7 Day Performance-0.20%5.85%4.11%2.20%1 Month Performance4.18%17.58%10.74%12.75%1 Year PerformanceN/A5.05%34.43%19.27% Alpha Cognition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACOGAlpha Cognition1.7311 of 5 stars$9.97+0.1%$20.00+100.6%N/A$159.72MN/A-8.31N/APositive NewsIOVAIovance Biotherapeutics4.6168 of 5 stars$2.01+7.5%$12.22+508.1%-64.0%$671.20M$164.07M-1.62500Analyst ForecastOptions VolumeGap UpHigh Trading VolumeURGNUrogen Pharma4.5082 of 5 stars$14.49+1.8%$32.86+126.8%+10.0%$668.13M$90.40M-4.56200TLRYTilray Brands1.8105 of 5 stars$0.66+13.1%$1.92+191.8%-60.7%$661.07M$788.94M-0.632,650Upcoming EarningsOptions VolumeTNGXTango Therapeutics1.6669 of 5 stars$6.09+2.7%$12.20+100.3%-31.9%$660.12M$40.99M-4.9990Positive NewsSTOKStoke Therapeutics4.2492 of 5 stars$12.06+1.7%$24.75+105.2%-5.4%$658.48M$36.56M15.27100PRMEPrime Medicine3.853 of 5 stars$4.80+10.3%$10.08+110.1%-20.8%$645.57M$3.85M-2.34234Gap DownHigh Trading VolumeDNTHDianthus Therapeutics1.3859 of 5 stars$20.03-0.1%$53.00+164.6%-21.7%$644.17M$6.24M-6.9580Positive NewsPHATPhathom Pharmaceuticals4.31 of 5 stars$9.06-1.3%$17.50+93.2%-21.0%$632.48M$55.25M-1.73110Positive NewsUPBUpstream Bio1.7838 of 5 stars$11.73+2.2%$56.50+381.7%N/A$631.00M$2.30M0.0038News CoverageXNCRXencor4.5069 of 5 stars$8.85+0.2%$28.00+216.4%-54.7%$629.85M$110.49M-2.89280Positive News Related Companies and Tools Related Companies IOVA Competitors URGN Competitors TLRY Competitors TNGX Competitors STOK Competitors PRME Competitors DNTH Competitors PHAT Competitors UPB Competitors XNCR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACOG) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Cognition Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpha Cognition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.